Progress on Development of the Live BCG Recombinant Vaccine Vehicle for Combined Vaccine Delivery
- 1 May 1995
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 754 (1), 214-221
- https://doi.org/10.1111/j.1749-6632.1995.tb44453.x
Abstract
Click on the article title to read more.This publication has 21 references indexed in Scilit:
- Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.The Journal of Experimental Medicine, 1994
- Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.The Journal of Experimental Medicine, 1993
- Expression of Escherichia coli ?-galactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responsesMolecular Microbiology, 1992
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991
- New use of BCG for recombinant vaccinesNature, 1991
- Construction and characterization of a Mycobacterium-Escherichia coli shuttle vectorPlasmid, 1991
- Lysogeny and transformation in mycobacteria: stable expression of foreign genes.Proceedings of the National Academy of Sciences, 1988
- Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.Proceedings of the National Academy of Sciences, 1988
- Introduction of foreign DNA into mycobacteria using a shuttle phasmidNature, 1987
- IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN LOCALISED CUTANEOUS LEISHMANIASISThe Lancet, 1987